InfuSystem Holdings Inc (INFU)
AMEXHealth CareMedical - DevicesSnapshot 2026-11-04
$13.15+2.73%
Close 2026-11-04 · 1-day change
AMEXHealth CareMedical - DevicesSnapshot 2026-11-04
QuarterlyIQ Insights · INFU
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 14.7% |
| Our one-year growth estimate | diamond | 6.5% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 8.3 percentage points more one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-11-04 · Compared with 28 industry peers · Company calendar date is not available
INFU — earnings in line
Dated 2026-11-05
“Results of Operations and Financial Condition” of this Current Report on Form 8-K and the press release attached hereto as Exhibit 99.1 shall not be deemed “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of such section, and shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.
Why it matters: Management targets 6% to 8% revenue growth and margins in the low to mid 20% range. The results will test both goals.
Watch forQ3 results show revenue growth at or above 6% and Adjusted EBITDA margin at or above 22%.
Also watch forQ3 results show revenue growth under 6% or an Adjusted EBITDA margin under 20%.
Why it matters: The company says faster claim processing is expanding from Wound Care into Oncology in 2026–2027. A rollout would show this plan is moving forward.
Supportive ifManagement confirms the billing system is live for Oncology claims. It also reports faster claim processing.
Worry ifManagement reports that the Oncology rollout is delayed beyond 2027 or has not begun by then.
Why it matters: Patient Services grew in Q1 and Q2, while Device Solutions fell year over year. Continued Patient Services growth would support the full-year revenue goal.
Watch forQ3 Patient Services revenue is above $24.8 million and total pro forma revenue growth is at least 6%.
Also watch forQ3 Patient Services revenue is at or below $24.8 million and total pro forma revenue growth is below 6%.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$134 on $10,000 · ±1.3% | How much price usually moves either way. |
| Bad day | $462 loss on $10,000 · 4.6% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $2,900 loss on $10,000 · 29.0% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.